Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,351 | -60,692 | -45,525 | -30,079 | -14,950 |
| Depreciation Amortization | 661 | 2,277 | 1,646 | 1,054 | 512 |
| Other Working Capital | -1,847 | -700 | -59 | -2,947 | -1,340 |
| Other Operating Activity | 2,446 | 11,557 | 8,548 | 5,338 | 2,420 |
| Operating Cash Flow | $-14,091 | $-47,558 | $-35,390 | $-26,634 | $-13,358 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -452 | -3,263 | -2,867 | -2,280 | -1,089 |
| Investing Cash Flow | $-452 | $-3,263 | $-2,867 | $-2,280 | $-1,089 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1 | -51 | -2 | -2 | N/A |
| Common Stock Issued | 134 | 783 | 627 | 595 | 282 |
| Financing Cash Flow | $133 | $732 | $625 | $593 | $282 |
| Beginning Cash Position | 143,345 | 193,434 | 193,434 | 193,434 | 193,434 |
| End Cash Position | 128,935 | 143,345 | 155,802 | 165,113 | 179,269 |
| Net Cash Flow | $-14,410 | $-50,089 | $-37,632 | $-28,321 | $-14,165 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,091 | -47,558 | -35,390 | -26,634 | -13,358 |
| Capital Expenditure | -452 | -3,263 | -2,867 | -2,280 | -1,089 |
| Free Cash Flow | -14,543 | -50,821 | -38,257 | -28,914 | -14,447 |